Department of Palliative Care, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
J Clin Oncol. 2023 Jan 20;41(3):579-589. doi: 10.1200/JCO.22.00849. Epub 2022 Oct 6.
Many hospitals have established goals-of-care programs in response to the coronavirus disease 2019 pandemic; however, few have reported their outcomes. We examined the impact of a multicomponent interdisciplinary goals-of-care program on intensive care unit (ICU) mortality and hospital outcomes for medical inpatients with cancer.
This single-center study with a quasi-experimental design included consecutive adult patients with cancer admitted to medical units at the MD Anderson Cancer Center, TX, during the 8-month preimplementation (May 1, 2019-December 31, 2019) and postimplementation period (May 1, 2020-December 31, 2020). The primary outcome was ICU mortality. Secondary outcomes included ICU length of stay, hospital mortality, and proportion/timing of care plan documentation. Propensity score weighting was used to adjust for differences in potential covariates, including age, sex, cancer diagnosis, race/ethnicity, and Sequential Organ Failure Assessment score.
This study involved 12,941 hospitalized patients with cancer (pre n = 6,977; post n = 5,964) including 1,365 ICU admissions (pre n = 727; post n = 638). After multicomponent goals-of-care program initiation, we observed a significant reduction in ICU mortality (28.2% 21.9%; change -6.3%, 95% CI, -9.6 to -3.1; = .0001). We also observed significant decreases in length of ICU stay (mean change -1.4 days, 95% CI, -2.0 to -0.7; < .0001) and in-hospital mortality (7% 6.1%, mean change -0.9%, 95% CI, -1.5 to -0.3; = .004). The proportion of hospitalized patients with an in-hospital do-not-resuscitate order increased significantly from 14.7% to 19.6% after implementation (odds ratio, 1.4; 95% CI, 1.3 to 1.5; < .0001), and do-not-resuscitate order was established earlier (mean difference -3.0 days, 95% CI, -3.9 to -2.1; < .0001).
This study showed improvement in hospital outcomes and care plan documentation after implementation of a system-wide, multicomponent goals-of-care intervention.
许多医院已经针对 2019 年冠状病毒病大流行制定了目标治疗计划;然而,很少有医院报告其结果。我们研究了一种多组分跨学科目标治疗计划对癌症内科住院患者重症监护病房(ICU)死亡率和医院结局的影响。
这项单中心的准实验设计研究包括在德克萨斯州 MD 安德森癌症中心的内科病房接受治疗的连续成年癌症患者,研究时间为实施前 8 个月(2019 年 5 月 1 日至 12 月 31 日)和实施后 8 个月(2020 年 5 月 1 日至 12 月 31 日)。主要结局是 ICU 死亡率。次要结局包括 ICU 住院时间、医院死亡率和护理计划文件的比例/时间。采用倾向评分加权法调整潜在协变量的差异,包括年龄、性别、癌症诊断、种族/民族和序贯器官衰竭评估评分。
这项研究共涉及 12941 名住院癌症患者(实施前 n = 6977;实施后 n = 5964),包括 1365 例 ICU 入院(实施前 n = 727;实施后 n = 638)。在多组分目标治疗计划启动后,我们观察到 ICU 死亡率显著降低(28.2% 21.9%;变化-6.3%,95%置信区间,-9.6 至-3.1; =.0001)。我们还观察到 ICU 住院时间(平均变化-1.4 天,95%置信区间,-2.0 至-0.7; <.0001)和院内死亡率(7% 6.1%,平均变化-0.9%,95%置信区间,-1.5 至-0.3; =.004)显著降低。实施后,住院患者中有院内不复苏医嘱的比例从 14.7%显著增加到 19.6%(比值比,1.4;95%置信区间,1.3 至 1.5; <.0001),并且不复苏医嘱的制定时间更早(平均差异-3.0 天,95%置信区间,-3.9 至-2.1; <.0001)。
这项研究表明,在实施系统的、多组分的目标治疗干预措施后,医院结局和护理计划文件得到了改善。